TY - JOUR AU - Hofman, Paul PY - 2019 TI - Is the onset of adverse effects of immunotherapy always bad news for the patients…?—certainly not! JF - Annals of Translational Medicine; Vol 7, Supplement 1 (March 27, 2019): Annals of Translational Medicine Y2 - 2019 KW - N2 - Despite the identification of promising and validated biomarkers the response to immunotherapy can be unexpected or variable, including rapid regression (complete or partial) of the tumor mass, stability, progression, pseudo progression or hyper tumor progression (1-5). Immunotherapy, in general, is less toxic than chemotherapy for patients with cancer. UR - https://atm.amegroups.org/article/view/23374